Merck secures voluntary licensing for experimental HIV prevention drug in developing nations

Merck has entered into voluntary licensing agreements to facilitate generic production of its experimental HIV prevention pill in low-income countries. The move aims to accelerate global access and scale manufacturing, though the drug's regulatory approval status remains pending.